Laborie Medical Names Chris Smith as CEO

Laborie Medical has appointed Chris Smith as its new CEO, effective September 22. Smith succeeds Michael Frazzette, who announced his retirement last month.

Smith boasts over 30 years of executive leadership experience in the healthcare and medical technologies industries. He’s previously served as CEO of NeoGenomics Laboratories, Ortho Clinical Diagnostics, and Cochlear Limited. He has also held several board positions at both private and public companies.

“The Laborie Board of Directors thanks Mike for his outstanding contributions to Laborie during his tenure as CEO,” said David Perez, chair of the board. “We look forward to working with Chris as Laborie’s new CEO, and we are confident that his experience and expertise make him the right leader to guide Laborie’s next chapter.”

“We look forward to working with Mike in his new capacity and thank him for his exceptional leadership of Laborie and partnership with Patricia Industries over the past eight years,” added Yuriy Prilutskiy, co-head of Patricia Industries. “During this time, Laborie has achieved significant growth, expanded its product portfolio and global presence, and fostered an innovative, high-performance culture. We are excited to partner with Chris to build on this momentum, and are confident that his leadership style, business acumen, and deep expertise in medical technology will position him to lead Laborie with impact and vision.”

Smith has been on Laborie’s board since 2023 to provide strategic counsel during a period of expansion. The company believes his familiarity with its mission and operations will allow a seamless transition to the CEO role.

“Laborie’s mission truly resonates with me, and I’m excited to work with such an exceptional team as we continue to drive innovation and enhance patient lives in our three leading platforms: urology, gastroenterology and OB,” said Smith.

In May 2024, the company introduced the Solar compact system and Solar anorectal manometry catheter, which it touts as the first disposable HRAM catheter on the market.